Correlation Between Enlivex Therapeutics and Marizyme
Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Marizyme at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Marizyme into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enlivex Therapeutics and Marizyme, you can compare the effects of market volatilities on Enlivex Therapeutics and Marizyme and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Marizyme. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Marizyme.
Diversification Opportunities for Enlivex Therapeutics and Marizyme
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Enlivex and Marizyme is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Marizyme in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marizyme and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Marizyme. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marizyme has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Marizyme go up and down completely randomly.
Pair Corralation between Enlivex Therapeutics and Marizyme
Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Marizyme. But the stock apears to be less risky and, when comparing its historical volatility, Enlivex Therapeutics is 4.58 times less risky than Marizyme. The stock trades about -0.07 of its potential returns per unit of risk. The Marizyme is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 4.00 in Marizyme on September 19, 2024 and sell it today you would lose (1.80) from holding Marizyme or give up 45.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 97.62% |
| Values | Daily Returns |
Enlivex Therapeutics vs. Marizyme
Performance |
| Timeline |
| Enlivex Therapeutics |
| Marizyme |
Enlivex Therapeutics and Marizyme Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enlivex Therapeutics and Marizyme
The main advantage of trading using opposite Enlivex Therapeutics and Marizyme positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Marizyme can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marizyme will offset losses from the drop in Marizyme's long position.| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
| Marizyme vs. Deere Company | Marizyme vs. Caterpillar | Marizyme vs. Lion Electric Corp | Marizyme vs. Nikola Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |